Balanced news tone
News Sentiment
OBIO sentiment intelligence
Orchestra BioMed Holdings Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-4.8% over one week, -2.7% over four weeks, trend inactive, and below fair value.
OBIO - Orchestra BioMed Holdings Inc Latest SEC Filings
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
OBIO - Orchestra BioMed Holdings Inc Latest SEC Filings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 11:30
- Source
- Finviz
Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Share Price, OBIO Stock News, OBIO Share Price & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 05:50
- Source
- Kalkine
Insider Sell: Darren Sherman Sells 15,000 Shares of Orchestra Bi
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 02 Jul 2026 22:44
- Source
- GuruFocus
Orchestra BioMed (OBIO) insider sells 15,000 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:17
- Source
- Stock Titan
Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2500 Growth Benchmark
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 19:59
- Source
- marketscreener.com
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 12:00
- Source
- marketscreener.com
Orchestra BioMed stock rises after Russell index addition
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Investing.com
Orchestra BioMed lands in Russell indexes tracking $12.2T
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 00:47
- Source
- Investing.com Canada
Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Investing.com Canada
Orchestra BioMed Holdings (OBIO) Bounces from Support: +2.26% Gain Signals Potential Recovery - Mean Reversion Trade
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- DonanımHaber
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 20:05
- Source
- GlobeNewswire
Orchestra BioMed (OBIO) Rebounds: Key Levels to Watch After 2% Gain - PCR Moving Average
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- dars.gov.et
Orchestra BioMed Holdings (OBIO) Slips Slightly as Stock Hovers Near Support - ETF AUM Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- DonanımHaber
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Market source
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 12:30
- Source
- GlobeNewswire
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 May 2026 11:42
- Source
- MT Newswires
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 12 May 2026 21:40
- Source
- Zacks
Orchestra BioMed Q1 Loss Narrows, Revenue Falls
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 12 May 2026 20:55
- Source
- MT Newswires
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 20:18
- Source
- GlobeNewswire
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 12:30
- Source
- GlobeNewswire
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView